Article

Ling, S; Dexter, A; Race, A M; Sharma, S; Hamm, G; Polanska, U M; Rosetta Consortium Cancer Research UK; Marshall, J F; Takats, Z; Brindle, K; Yunera, M O; Poulogiannis, G; Campbell, A D; Sansom, O J; Goodwin, R J A; Bunch, J; Barry, S T (2025) Use of metabolic imaging to monitor the heterogeneity of tumour response following therapeutic mTORC1/2 pathway inhibition. Disease Models & Mechanisms, 18 (2). DMM050804